“The short-term trend of Nifty remains choppy. Some more consolidation movement or minor weakness is likely before showing a decisive upside breakout of the crucial overhead resistance around 19,850 levels in the short term. Immediate support is placed at 19,600 levels,” said Nagaraj Shetti of HDFC Securities.
Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25
Biocon’s board has approved the acquisition of 1.5% equity in Biocon Biologics for Rs 550 crore, increasing its stake to 90.2%. The deal is expected
January 30, 2025